Recurrent Visceral Leishmaniasis in HIV Co-Infection
Recruiting · NCT07487350 · Observational (researchers observe without assigning treatment) · Lead sponsor: Institute of Tropical Medicine, Belgium
View the official record on ClinicalTrials.gov →What this trial is about
The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in Ethiopia
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- VL-HIV infection 1.1. VL: microscopically confirmed parasite presence in spleen or bone marrow tissue at first episode or relapse; for known active chronic cases: decision to treat VL 1.2. HIV: confirmed viral infection (new or past)
- ≥18 years
Exclusion criteria
- Not willing to provide written informed consent
- Not willing to adhere to the follow-up visits
- Mentally or physically incapable to participate in the study (to the discretion of the treating physician)
Where it is running
1 location listed.
- University of Gondar - Gonder, Ethiopia